02-392-4 Me. Code R. § 25-1

Current through 2024-51, December 18, 2024

Section 392-4-25-1 - New Prescription Drug Orders

With each new prescription dispensed, the pharmacist shall:

1. Review

Review the individual's patient profile for the following potential drug therapy problems:

A. Therapeutic duplication;

B. Drug disease contraindications when such information has been provided to the pharmacist;

C. Drug interactions;

D. Incorrect drug dosage or duration;

E. Drug allergy interactions; and

F. Clinical abuse or misuse.

2. Explain

Orally explain to the patient or the authorized agent of the patient the directions for use and any additional information, in writing if necessary, to assure the proper utilization of the medication or device prescribed. Such explanations may include, but are not limited to, the following:

A. Name and description of the medication;

B. Dosage form, dosage, route of administration and duration of therapy;

C. Special directions, precautions for the preparation, administration and use by the patient;

D. Common significant side effects, adverse effects of interactions, and therapeutic contraindications;

E. Techniques for self monitoring;

F. Proper storage;

G. Refill information; and

H. Actions in the case of missed dosages.

For prescriptions which are not supplied directly to the patient or to the caregiver responsible for administering the medication or device to the patient, the pharmacist shall make the required counseling available to the patient through access to a telephone service which is toll-free for long distance calls.

02-392 C.M.R. ch. 4, § 25-1